CBD is a well-liked activator of TRPV2 receptors, but THC is considered to be one of the most potent cannabinoid on this target. The clinical significance of THC’s interaction with TRPV2 remains a focus of investigation. Dronabinol is classified to be a pregnancy Class C drug, because i